Skip to content
  • CAT
  • ESP
  • ENG
  • About us
  • Contact
El·lipse
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • Research
  • Public engagement
  • Scientific life
  • Community
  • About us
  • Contact
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • CAT
  • ESP
  • ENG

Interview

23.03.2021

Denise Naniche (ISGlobal): “The pandemic has shown us that diseases do not know borders”

A plant-based diet is healthy and the most sustainable for the planet. Una dieta basada en vegetales es saludable y la más sostenible para el planeta. Credit:Red Zeppelin a Unsplash
17.03.2021

An interdisciplinary aproach to takle planetary health

Sergi Beltran works with a multidisciplinary team of software engineers, bioinformatics and clinical geneticists to develop and grow the RD-Connect platform. Source: CNAG-CRG
16.03.2021

Joining efforts to diagnose rare diseases

GRIB & DCEXS-UPF members that have studied the behaviour of users with depression through their tweets. Ángela Leis & Ferran Sanz (third and fifth on the right side)
02.03.2021

Twitter, a good resource to study depression

Eduard Sabidó, al centre de la fotografia, junt a dos membres de la Unitat de Proteòmica CRG-UPF.
09.02.2021

Eduard Sabidó (CRG): “In a few years all researchers will use machine learning algorithms”

05.02.2021

Maria Pia Cosma (CRG): “We want to maintain donors’ eyes alive for one month”

Antonio Garcia de Herreros has been a group leader at IMIM for 28 years.
20.01.2021

Antonio García de Herreros (IMIM): “Things are not relevant when you publish them, but when the scientific community accepts them”

08.12.2020

Tomàs Marquès-Bonet (IBE): “We need to understand the genetic diversity of species to preserve it”

Eva Maria Novoa is one of the last group leaders to join the CRG. She's telling us about her scientific career.
01.12.2020

Eva Maria Novoa (CRG): “It is amazing to find answers to the mysteries that fascinate us”

Rafael Vilasanjuan, director of ISGlobal's Global Analysis and Development Department, is involved in the worldwide distribution of the Covid19 vaccine through the CovaxFacility platform.
09.10.2020

Rafa Vilasanjuan (ISGlobal): “We will have vaccines, but they will not be available to everyone within the first year”

From left to right, Tomàs Marquès-Bonet and Salvador Carranza, former and new IBE director, respectively.
17.06.2020

Face to face: the outgoing and incoming directors of the IBE reflect on the centre

Joaquín Arribas became the new IMIM director in March 2020 - just in the midst of the coronavirus crisis.
09.06.2020

Joaquín Arribas (IMIM’s director): “We want to be the bridge between the research close to the patient and the PRBB high-tech”

El·lipse is published by the PRBB Communications and Corporate Relations Area.

Dr Aiguader, 88, 08003 Barcelona, Spain

For any suggestions or collaborations please contact us at ellipse@prbb.org

  • Read past print editions
  • About El·lipse
  • About the PRBB
  • Legal disclaimer
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
© 2025 El·lipse, PRBB
  • Home
  • News
  • Our picks
This website uses cookies that provide us with personal information, such as data associated with your browsing. If you click on I AGREE, both we and our Partners can install cookies or access non-sensitive information on your device in order to facilitate the reproduction of content, provide features on social networks, create profiles and compile statistics on traffic and usability in our website. You can get MORE INFORMATION by accessing our COOKIES POLICY. I agree More information
Privacy & Cookies Policy
Necessary Always Enabled

Subscribe to our mailing list
Want to be the first to know everything that goes on at the biggest biomedical research hub in Southern Europe? Subscribe to the el·lipse newsletter!

We will send you an email with the latest news.

See you soon!

*Required field

Field is not valid
You have to authorize data treatment

At any time, you can exercise the rights of access, rectification, opposition, portability, limitation to treatment and deletion of the data subject to treatment by clicking on the links "Update data" and "Unsubscribe", sending a letter indicating the right exercised to the postal address indicated at the bottom or to the following email address ellipse@prbb.org